Systematic Review

Accepted on 15 May 2024

Association of Immune Checkpoint Inhibitors with SARS-CoV-2 Infection Rate and Prognosis in Patients with Solid Tumors: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Lin Sun
Fangmin Zhao
Yuying Xiang
Shuyi Chen
Qijin Shu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1259112

Review

Accepted on 15 May 2024

Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lea Berland
Zeina Gabr
Michelle Chang
Marius Ilié
Veronique Hofman
Guylène Rignol
Francois Ghiringhelli
Baharia Mograbi
Mohamad Rashidian
Paul Hofman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384121

Case Report

Accepted on 15 May 2024

Successful Treatment with Tislelizumab Plus Chemotherapy for SMARCA4-deficient Undifferentiated Tumor: A Case Report

in Cancer Immunity and Immunotherapy

Wen Dong
Anli Dai
Zhijun Wu
Jiangtao Wang
Tao Wu
Yangfeng Du
Wei Tian
Jiang Zheng
Yan Zhang
Wang Hongming

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371379

Original Research

Published on 15 May 2024

Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer

in Cancer Immunity and Immunotherapy

A-Rum Yoon
Ao Jiao
JinWoo Hong
Bomi Kim
Chae-Ok Yun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360436

258 views

Editorial

Published on 15 May 2024

Editorial: Immunologic tumor microenvironment modulators for turning “cold” tumors to “hot” tumors

in Cancer Immunity and Immunotherapy

Mazdak Ganjalıkhani-Hakemi
Gulderen Yanikkaya Demirel
Xin He
Chengwu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425136

117 views

Review

Published on 15 May 2024

The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers

in Cancer Immunity and Immunotherapy

Shi-Yu Qi
Miao-Miao Yang
Chong-Yang Li
Kun Yu
Shou-Long Deng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407649

198 views

Systematic Review

Published on 15 May 2024

The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review

in Cancer Immunity and Immunotherapy

Lei Yang
Xiujing Cui
Fengpeng Wu
Zifeng Chi
Linlin Xiao
Xuan Wang
Zezheng Liang
Xiaoning Li
Qiyao Yu
Xueqin Lin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392499

175 views

Editorial

Published on 15 May 2024

Editorial: Anti-tumor activity of cytotoxic immune cells: basic research and clinical perspectives

in Cancer Immunity and Immunotherapy

Malgorzata Firczuk
Magdalena Winiarska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428565

Original Research

Published on 15 May 2024

The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer

in Cancer Immunity and Immunotherapy

Han Wang
Junchang Zhang
Zhuoqi Wei
Songyao Chen
Jiabin Zheng
Yong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1364979

150 views

Brief Research Report

Published on 15 May 2024

Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells

in Cancer Immunity and Immunotherapy

Giulia Corradi
Dorian Forte
Gianluca Cristiano
Andrea Polimeno
Marilena Ciciarello
Valentina Salvestrini
Lorenza Bandini
Valentina Robustelli
Emanuela Ottaviani
Michele Cavo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386517

187 views

Original Research

Accepted on 14 May 2024

Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer

in Cancer Immunity and Immunotherapy

Takuro Kobayashi
Masayoshi Nagata
Tsuyoshi Hachiya
Haruhiko Wakita
Yoshihiro Ikehata
Keiji Takahashi
Jun Lu
Yiming Jin
YAN LU
Hisamitsu Ide

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372771

Original Research

Accepted on 14 May 2024

Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score

in Cancer Immunity and Immunotherapy

Qi Wang
Shugui Sheng
Yiqi Xiong
Ming Han
Ronghua Jin
Caixia Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409443

Mini Review

Accepted on 14 May 2024

Manipulating Regulatory T Cells: is it the Key to Unlocking Effective Immunotherapy for Pancreatic Ductal Adenocarcinoma?

in Cancer Immunity and Immunotherapy

Shivan Sivakumar
Henry Smith
Edward Arbe-Barnes
Enas Abu Shah

Frontiers in Immunology

doi 10.3389/fimmu.2024.1406250

Review

Accepted on 14 May 2024

Eating away cancer: The potential of diet and the microbiome for shaping immunotherapy outcome

in Cancer Immunity and Immunotherapy

Ngoc-Trang Adrienne Nguyen
Yan Jiang
Jennifer McQuade

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409414

Review

Published on 14 May 2024

Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals

in Cancer Immunity and Immunotherapy

Narges Abolhasanzadeh
Sajed Sarabandi
Bahar Dehghan
Vahidreza Karamad
Cigir Biray Avci
Behrouz Shademan
Alireza Nourazarian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1333563

309 views

Original Research

Published on 14 May 2024

Ex vivo expansion in a clinical grade medium, containing growth factors from human platelets, enhances migration capacity of adipose stem cells

in Cancer Immunity and Immunotherapy

Francesco Agostini
Carla Vicinanza
Elisabetta Lombardi
Francesco Da Ros
Miriam Marangon
Samuele Massarut
Mario Mazzucato
Cristina Durante

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404228

244 views

Navigation group

Articles

Association of Immune Checkpoint Inhibitors with SARS-CoV-2 Infection Rate and Prognosis in Patients with Solid Tumors: A Systematic Review and Meta-Analysis

Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors

Successful Treatment with Tislelizumab Plus Chemotherapy for SMARCA4-deficient Undifferentiated Tumor: A Case Report

Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer

Editorial: Immunologic tumor microenvironment modulators for turning “cold” tumors to “hot” tumors

The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers

The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review

Editorial: Anti-tumor activity of cytotoxic immune cells: basic research and clinical perspectives

The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer

Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells

Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer

Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score

Manipulating Regulatory T Cells: is it the Key to Unlocking Effective Immunotherapy for Pancreatic Ductal Adenocarcinoma?

Eating away cancer: The potential of diet and the microbiome for shaping immunotherapy outcome

Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals

Ex vivo expansion in a clinical grade medium, containing growth factors from human platelets, enhances migration capacity of adipose stem cells